butylene glycol dicaprylate/dicaprate hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive restriction found for butylene glycol dicaprylate/dicaprate. No peer‑reviewed evidence of developmental or reproductive toxicity specific to this ingredient was identified in the regulatory literature; esters of medium‑chain fatty acids and glycols are not classically associated with teratogenicity. Dermal cosmetic use implies low but measurable percutaneous exposure for adults (CosIng / PubChem show cosmetic use as emollient), so exposure scored as low. Sources checked: ECHA Annex VI (no harmonised H360/H361), CosIng, PubChem, CIR (no safety flag).
Pregnancy-safe products containing butylene glycol dicaprylate/dicaprate










Related ingredients
Frequently asked questions
- butylene glycol dicaprylate/dicaprate hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive restriction found for butylene glycol dicaprylate/dicaprate. No peer‑reviewed evidence of developmental or reproductive toxicity specific to this ingredient was identified in the regulatory literature; esters of medium‑chain fatty acids and glycols are not classically associated with teratogenicity. Dermal cosmetic use implies low but measurable percutaneous exposure for adults (CosIng / PubChem show cosmetic use as emollient), so exposure scored as low. Sources checked: ECHA Annex VI (no harmonised H360/H361), CosIng, PubChem, CIR (no safety flag).
- butylene glycol dicaprylate/dicaprate emzirirken güvenli mi?
- No evidence of lactation/transfer concerns or reproductive toxicity in available regulatory/peer review sources. Given low dermal absorption from topical esters, maternal systemic exposure from cosmetic use is expected to be low; no data for milk transfer were found.
- butylene glycol dicaprylate/dicaprate bebek cildi için güvenli mi?
- No infant‑specific reproductive or developmental hazards identified. Because infant skin has higher surface‑area‑to‑weight and an immature barrier, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2). Ingredient is used as an emollient/skin conditioning agent (CosIng/PubChem) with no infant‑specific restrictions identified.
- VeriMom butylene glycol dicaprylate/dicaprate nasıl puanlıyor?
- VeriMom butylene glycol dicaprylate/dicaprate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte butylene glycol dicaprylate/dicaprate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.